MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Medtronic (NYSE:MDT) maintained its lead on other devices makers, again topping the 30-day internet chatter list amid a slew of reports regarding new clinical results on transcatheter aortic valve implantation technologies, neurostimulators, renal denervation and more.
Johnson & Johnson (NYSE:JNJ) was a far 2nd, with most of this month’s stories focused on legal battles and the company’s latest earnings report. Dialysis provider Fresenius (NYSE:FMS) made a surprise appearance on the roster as the company continues its long-running battle with Baxter (NYSE:BAX).
St. Jude Medical (NYSE:STJ) and Covidien (NYSE:COV) closed the list at a dead heat, with a raft of St. Jude stories on clinical trials, patent battles and more, while Covidien laid low during the month.
Medtronic
- Medtronic launches Symplicity renal denervation trial in Japan – October 1
- Medical device cybersecurity a “high priority” for Medtronic, says CEO – October 2
- Medtronic closes 1st phase of Symplicity renal denervation feasibility trial – October 3
- Medtronic: Study shows InterStim neurostim device helps overactive bladder – October 4
- Medtronic touts launch, closes clinical study for below-the-knee PAD devices – October 5
- Direct aortic approach feasible for Medtronic’s CoreValve heart implant – October 8
- Diabetes: Medtronic sues Insulet over OmniPod device – October 9
- Heart valves: Edwards Lifesciences, Medtronic to face stiffer competition – October 9
- Post-CoreValve pacemaker use may be on the decline – October 11
- Medtronic lands patent for implant recharger that may fit in blankets, clothing – October 11
- Medtronic puts more skin in China with $66M investment in LifeTech – October 15
- Medtronic launches Japan’s 1st MRI-friendly pacemaker system – October 18
- TCT 2012: Medtronic’s CoreValve system shows high survival rate – October 22
- Selection issues stymie Medtronic’s erectile dysfunction stenting study – October 24
- Senate report blasts Medtronic over Infuse bone protein – October 25
- Medtronic lands FDA win for pediatric oxygenation system – October 26
- TAVI: Medtronic’s next-gen Engager looks good in 1st pivotal study results – October 30
- Spurned inventor sues over Medtronic licensing agreement – October 31
Johnson & Johnson
- Spectralytics asks appeals court to send $22M Cordis lawsuit down for more damages – October 2
- Johnson & Johnson investing $225M in 4 plants in Puerto Rico – October 4
- Bellwether trials of DePuy’s New Jersey hip lawsuit set for late next year – October 11
- Johnson & Johnson reports Q3 earnings slip 18%, boosts outlook – October 16
- Johnson & Johnson hits 52-week high on boosted earnings forecast – October 16
- Legal: 1st DePuy metal-on-metal hip lawsuit hits Ireland – October 16
- DePuy Synthes, Brainlab ink integration pact – October 26
- J&J surgical stapler recall gets Class I status from the FDA – October 29
Fresenius
- Court overturns Fresenius’ $83M Medicare fraud loss – October 11
- Baxter loses bid for appeal in patent war with Fresenius – October 30
St. Jude Medical
- St. Jude touts clinical findings for migraine-treating neurostim implant – October 3
- St. Jude Medical’s deal with Optim lead insulation maker AorTech is in trouble – October 9
- St. Jude Medical launches cardiovascular “GPS” technology – October 9
- Report: St. Jude probed Riata problems in 2005 – October 11
- Trial begins today in St. Jude Medical/Volcano patent spat – October 15
- St. Jude Medical slides on potential FDA warning, lowered outlook – October 17
- St. Jude Medical-backed Nanostim drums up $10M – October 18
- Volcano claims victory in 1st patent trial against St. Jude Medical – October 22
- Volcano gains 7% on legal win over St. Jude Medical as 2nd trial begins – October 23
- St. Jude Medical touts PressureWire FFR cost-effectiveness study – October 24
- St. Jude Medical ticks up on positive PressureWire data – October 24
- FDA sends St. Jude Medical 483 letter on California plant – October 24
- St. Jude Medical slides on negative results from heart implant trial – October 25
- Jury finds for St. Jude Medical in 2nd patent spat with Volcano – October 25
Covidien
